Login
Rapport Therapeutics, Inc. logo

Rapport Therapeutics, Inc.

rapportrx.com

What Do They Do?

Develops small-molecule precision medicines for patients with neurological or psychiatric disorders.

How Do They Make Money?

No revenue reported yet.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
vs $0 in Q3 FY2025
Net income
▼ −49% (Loss)
vs −$26.9M in Q3 FY2025

Who Do They Compete With?

Competes with SK Life Science, UCB, Eisai, Xenon Pharmaceuticals, Biohaven, Praxis Precision Medicines, ES Therapeutics Australia, Supernus Pharmaceuticals, and Bristol Meyers Squibb

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support